Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | CEBPA-51 |
| Trade Name | |
| Synonyms | MTL-CEBPA|NOV340 SMARTICLES|MTL-501 |
| Drug Descriptions |
CEBPA-51 (MTL-CEBPA) is a small activating RNA that induces expression of CEBPA mRNA and protein, which subsequently leads to upregulation of albumin, and thereby potentially inhibiting cell growth (PMID: 28882451, PMID: 32357963). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C126800 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| CEBPA-51 | CEBPA-51 | 0 | 0 |
| CEBPA-51 + Pembrolizumab | CEBPA-51 Pembrolizumab | 0 | 1 |
| CEBPA-51 + Sorafenib | CEBPA-51 Sorafenib | 0 | 1 |